Genotyping Assay Market Size, Share, By Offerings (Reagents & Kits, Instruments, Software, and Services), Techniques (Microarray, DNA Sequencing, Polymerase Chain Reaction (PCR), Mass Spectrometry, Electrophoresis, and Others), Application (Genetic Disease Diagnosis, Forensic Analysis, Pharmacogenomics, Agriculture, and Others), End-User (Diagnostics & Research Laboratories, Academic Institutes, Pharmaceutical & Biotechnological Companies, and Others), and Region - Trends, Analysis, and Forecast till 2035

• Illumina, Inc
• QIAGEN
• Thermo Fisher Scientific Inc
• Agilent Technologies, Inc
• GE Healthcare
• Standard BioTools
• Adaptive Biotechnologies
• Oxford Nanopore Technologies plc
• F. Hoffmann-La Roche Ltd
• PerkinElmer
• Twist Bioscience
• Bio-Rad Laboratories, Inc
• Macrogen, Inc.
• Eurofins Scientific

Recent News:

BD company introduced transforming cervical cancer protection with the BD Onclarity HPV assay in November 2024. This assay was approved by FDA, includes extended genotyping, which differentiated HPV types based on risk levels. This precision enables targeted follow-up care, where individuals with high-risk of genotypes such as HPV 16 or 18 can proceed directly to colposcopy.